Alumis. Every tracked FinTwit mention of $ALMS, newest first. 3 mentions since the first on Jan 6, 2026. See the price chart.
January 2026 · 3 mentions
Jan 6
InvestmentGuru — $ALMS soared 84.26% after the company said both of its phase three trials of its envudeucitinib drug for moderate-to-severe plaque psoriasis met all primary and secondary endpoint…↗
Jan 6
Adam Feuerstein ✡️ — $ALMS:
At Week 24, on the higher hurdle skin clearance measures, approximately 65% of patients achieved PASI 90, and more than 40% achieved PASI 100, on average across both trial…↗